Paraneoplastic pemphigus is associated with the DRB1*03 allele

Journal of Autoimmunity

Volumn 20, Issue 1, 2003, Pages 91-95

  Martel, Philippe ^a   Loiseau, Pascale ^b   Joly, Pascal ^a   Busson, Marc ^a   Lepage, Virginia ^b   Mouquet, Hugo ^a   Courville, Philippe ^a   Flageul, Béatrice ^b   Charron, Dominique ^b   Musette, Philippe ^a   Gilbert, Danièle ^a   Tron, François ^a  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Bullous skin disease; Desmoglein; DR3; Human leukocyte antigen; Plakin

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HLA SYSTEM; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PARANEOPLASTIC SYNDROME; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0037322284     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-8411(02)00092-6     Document Type: Article

References (24)

1. Anhalt G.J., Diaz L.A. Prospects for autoimmune disease: research advances in pemphigus. JAMA. 285:2001;652-654.
2. Anhalt G.J., Kim S.C., Stanley J.R., Korman H.J., Jabs D.A., Kory M., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 323:1990;1729-1735.
3. Joly P., Thomine E., Gilbert D., Verdier S., Delpech A., Prost C., et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol. 103:1994;65-72.
4. Amagai M., Nishikawa T., Nousari H.C., Anhalt G.J., Hashimoto T. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 102:1998;775-782.
5. Ahmed A.R., Yunis E.J., Khatri K., Wagner R., Notani G., Awdeh Z., et al. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA. 87:1990;7658-7662.
6. Ahmed A.R., Wagner R., Khatri K., Notani G., Alper C.A., Awdeh Z., et al. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA. 88:1991;5056-5060.
7. Gonzalez-Escribano M.F., Jimenez G., Walter K., Montes M., Perez-Bernal A.M., Rodriguez M.R., et al. Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris. Tissue Antigens. 52:1998;275-278.
8. Lombardi M.L., Mercuro O., Ruocco V., Lo Schiavo A., Lombari V., Guerrera V., et al. Common human leukocyte antigen allelesin pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol. 113:1999;107-110.
9. Loiseau P., Lecleach L., Prost C., Lepage V., Busson M., Bastuji G., et al. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun. 15:2000;67-73.
10. Miyagawa S., Amagai M., Niizeki H., Yamashina Y., Kaneshige T., Nishikawa T., et al. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens. 54:1999;333-340.
11. Moraes M.E., Fernandez-Vina M., Lazaro A., Diaz L.A., Filho G.H., Friedman H., et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens. 49:1997;35-40.
12. Wucherpfennig K.W., Yu B., Bhol K., Monos D.S., Argyris E., Karr R.W., et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA. 92:1995;11935-11939.
13. Lin M.S., Swartz S.J., Lopez A., Ding W., Fairley J.A., Diaz L.A., et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest. 99:1997;31-40.
14. Lin M.S., Swartz S.J., Lopez A., Ding X., Fairley J.A., Diaz L.A. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1. J Invest Dermatol. 109:1997;734-737.
15. Lin M.S., Fu C.L., Aoki V., Hans-Filho G., Rivilti E.A., Moraes J.R., et al. Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest. 105:2000;207-213.
16. Hertl M., Amagai M., Sundaram H., Stanley J., Ishii K., Katz S.I. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol. 110:1998;62-66.
17. Hertl M., Karr R.W., Amagai M., Katz S.I. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals. J Invest Dermatol. 110:1998;388-392.
18. Hertl M., Riechers R. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris. J Dermatol. 26:1999;748-752.
19. Riechers R., Grotzinger J., Hertl M. HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy. Autoimmunity. 30:1999;183-196.
20. Camisa C., Helm T.N. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol. 129:1993;883-886.
21. Joly P., Richard C., Gilbert D., Courville P., Chosidow O., Roujeau J.C., et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol. 43:2000;619-626.
22. Hashimoto T., Amagai M., Watanabe K., Chorzelski T.P., Bhogal B.S., Black M.M., et al. Characterization of paraneoplastic pemphigus antigens by immunoblot analysis. J Invest Dermatol. 104:1995;829-834.
23. Martel P., Gilbert D., Busson M., Loiseau P., Lepage V., Drouot L., et al. Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus. Genes Immunity. 3:2002;205-210.
24. Price P., Witt C., Allcock R., Sayer D., Garlepp M., Choy Kok C., et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 167:1999;257-274.